Russia's permanent mission, Health Ministry to present Sputnik V vaccine at UN today

Moscow: Russia`s permanent mission to the United Nation and its Health Ministry will hold a presentation, which will provide detailed information on the Russian Sputnik V vaccine against the novel coronavirus disease (COVID-19)/

The spokesman of Russia’s UN mission Fyodor Strzhizhovsky made this announcement about the Sputnik V vaccine.

During a speech at the UN General Assembly in September, Russian President Vladimir Putin suggested that the organisation`s employees be provided with the Russian vaccine against coronavirus free of charge. 

Russia`s Permanent Representative to the UN Vassily Nebenzia, in turn, did not rule out that the vaccine developers would present it at the UN headquarters.

"On Wednesday, December 2, a presentation of the Russian Sputnik V vaccine will take place. Russian Health Minister Mikhail Murashko, Russia`s Permanent Representative to the UN Vassily Nebenzia, and head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriyev will take part in the event," Strzhizhovsky said.

A tweet from Russia's UN Mission also confirmed this.

2dekabrja v 9.30 utra po N'ju-Iorku sostoitsja meroprijatie <> 31-i specsessii GA OON <<#SputnikV: vakcina ot COVID-19>> @sputnikvaccine pri uchastii Ministra zdravookhranenija M.A.Murashko @MINZDRAV_RF, RFPI @rdif_press i NICEhM im. N.F.Gamalei.
Prjamaja transljacija po @UNWebTV. pic.twitter.com/zZvyf8qNqe

— Russian Mission UN (@RussiaUN) December 1, 2020

He said a virtual event entitled "Sputnik V: Vaccine Against COVID-19" will be held on the sidelines of a special session of the UN General Assembly. During the meeting, detailed information on the Russian vaccine will be presented.

In August, Russia`s Health Ministry registered the world`s first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Centre. It was named Sputnik V. 

The vaccine is based on a well-studied and validated human adenoviral vector platform, the important benefits of which are safety, efficacy and no long-term adverse effects.